Evidence map›Paper›PMID 42292230›Full record

ArticleFrontiers in medicine2026

Vitamin D-related genetic variants as predictive biomarkers for breast cancer in Jordanian women.

Laith N Al-Eitan, Maryam K Alasmar, Mohammed S Alorjani, Lina M Sarhan, Sakher S Sammour, Farah N Aladwan, Hadil A Al Refai, Sara S Hasanat, Mira S Quran, Mansour A Alghamdi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Laith N Al-EitanDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
Maryam K AlasmarDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
Mohammed S AlorjaniDepartment of Pathology and Microbiology, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Lina M SarhanDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
Sakher S SammourDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
Farah N AladwanDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
Hadil A Al RefaiDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
Sara S HasanatDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
Mira S QuranDepartment of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
Mansour A AlghamdiDepartment of Anatomy, College of Medicine, King Khalid University, Abha, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vitamin D exerts a protective role in carcinogenesis by regulating signaling pathways implicated in tumor growth and progression. Variants in CYP2R1, CYP24A1, CYP27B1, and DBP have been reported to influence circulating 25(OH)D concentrations and provide evidence for a hypothesis that these polymorphisms may be associated with breast cancer risk by altering vitamin D metabolism and signaling. Therefore, the present study has been designed to assess the correlation of these gene polymorphisms with susceptibility to breast cancer. Methods: A case-control study was encompassed, including 300 patients with breast cancer and 300 healthy controls. Genotyping of CYP2R1, CYP27B1, CYP24A1, and DBP polymorphisms was determined employing PCR-based restriction fragment length polymorphism (RFLP) assays. Each of the polymorphisms was assessed for association with breast cancer susceptibility using multiple statistical approaches. Results: Significant associations were observed for CYP2R1 rs12794714 and CYP27B1 rs10877012, with the GG genotype of CYP2R1 and the TG genotype of CYP27B1 associated with a reduced risk of breast cancer. In contrast, no significant associations were observed for CYP2R1 rs10741657, CYP24A1 rs2248359, or DBP rs7041 and rs4588 variants. Conclusion: Our study suggests that certain genotypes in CYP2R1 and CYP27B1 might provide protective influences against the development of breast cancer in Jordanian females, although further studies are recommended to validate the results.

Indexed as

breast cancerCYP24A1CYP27B1CYP2R1DBPpolymorphism

Identifiers

PMID42292230
PMCPMC13253258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.